Resverlogix Corp (RVX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVX.TO | ONCO.NE | DTC.CN | ||
| Company | Resverlogix Corp | Onco-Innovations Limited | Defence Therapeutics Inc | ||
| Price Information | |||||
| Exchange | TSX | Cboe CA | CNSX | ||
| Open | 0.1200 | 0.6600 | 0.6400 | ||
| High | 0.1200 | 0.6900 | 0.6600 | ||
| Low | 0.1100 | 0.6300 | 0.6000 | ||
| Latest | 0.1200 | 0.6300 | 0.6000 | ||
| Change | -0.0050 | -0.0200 | -0.0200 | ||
| % Change | -4.00% | -3.08% | -3.23% | ||
| Volume | 152,178 | 54,500 | 46,589 | ||
| 20-Day Average Volume | 52,166 | 28,526 | 52,182 | ||
| Previous Close | 0.1250 | 0.6500 | 0.6200 | ||
| Industry | TSX Biotechnology | N/A | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1115 | 0.6950 | 0.6105 | ||
| 20-Day Raw Stochastic | 62.50% | 27.59% | 64.29% | ||
| 20-Day Relative Strength | 55.65 | 36.53 | 50.91 | ||
| Weighted Alpha | +5.79 | -71.70 | -50.91 | ||
| Today's Opinion | 72% Buy | 100% Sell | 56% Sell | ||
| Previous Opinion | 72% Buy | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.09% since 03/02/26 | -1.43% since 03/02/26 | +4.92% since 03/02/26 | ||
| Low | 0.1100 on 03/09/26 | 0.6100 on 03/05/26 | 0.5900 on 03/04/26 | ||
| High | 0.1350 on 03/05/26 | 0.7000 on 03/04/26 | 0.6700 on 03/06/26 | ||
| 1-Month | |||||
| %Chg | +4.35% since 02/09/26 | -16.87% since 02/09/26 | +4.92% since 02/09/26 | ||
| Low | 0.0950 on 02/23/26 | 0.6100 on 03/05/26 | 0.5500 on 02/11/26 | ||
| High | 0.1350 on 03/05/26 | 0.9000 on 02/26/26 | 0.6900 on 02/23/26 | ||
| 3-Month | |||||
| %Chg | unch since 12/09/25 | -54.00% since 12/09/25 | -24.71% since 12/09/25 | ||
| Low | 0.0850 on 12/29/25 | 0.6100 on 03/05/26 | 0.5200 on 01/21/26 | ||
| High | 0.1350 on 03/05/26 | 1.7500 on 12/11/25 | 0.8600 on 12/11/25 | ||
| 6-Month | |||||
| %Chg | +26.32% since 09/09/25 | -62.70% since 09/09/25 | -9.86% since 09/09/25 | ||
| Low | 0.0850 on 12/29/25 | 0.6100 on 03/05/26 | 0.5200 on 01/21/26 | ||
| High | 0.1500 on 12/03/25 | 1.9800 on 09/22/25 | 0.9300 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,918 | 36,255 | 35,569 | ||
| Shares Outstanding, K | 287,344 | 56,177 | 57,370 | ||
| Annual Sales | 0 | 65,291 | 0 | ||
| Annual Net Income | -7,635,000 | -8,494,596 | -3,522,072 | ||
| Last Quarter Sales | 0 | 69,878 | 0 | ||
| Last Quarter Net Income | -951,000 | -3,611,323 | -1,521,503 | ||
| 60-Month Beta | 0.73 | N/A | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/13/25 | -0.07 on 12/15/25 | -0.03 on 02/20/26 | ||
| Latest Earnings Date | 03/30/26 | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||